1998
DOI: 10.1016/s0003-4975(98)00599-2
|View full text |Cite
|
Sign up to set email alerts
|

Completion pneumonectomy: analysis of operative mortality and survival

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
28
1
1

Year Published

2000
2000
2013
2013

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 43 publications
(32 citation statements)
references
References 12 publications
2
28
1
1
Order By: Relevance
“…[2][3][4][5][6][7][8][9][10][11][12][13][14] In the present study, the actuarial 5-year overall survivals after CP for all malignancy were 49.0%. Accordingly, the good long-term survival of malignancy suggests that CP is one of the treatments of choice for selected patients if complete resection is possible.…”
Section: Discussionmentioning
confidence: 76%
See 2 more Smart Citations
“…[2][3][4][5][6][7][8][9][10][11][12][13][14] In the present study, the actuarial 5-year overall survivals after CP for all malignancy were 49.0%. Accordingly, the good long-term survival of malignancy suggests that CP is one of the treatments of choice for selected patients if complete resection is possible.…”
Section: Discussionmentioning
confidence: 76%
“…2) Maneuvers such as intrapericardial blood vessel ligation, division of the bronchus first, local application of glues and hemostatic agents, and bronchial reinforcement were routinely used to avoid 4,8) Advanced age, preoperative corticosteroid use, or low operative hemoglobin, 11) and renal failure 14) were reported to be the significant risk factors based on the multivariate analysis. In the present study, no patient had preoperative corticosteroid use or renal failure.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Though Muysoms et al [10] could not find a significant difference between the mortality rates of malignant and benign groups in his series, he found a significant difference (13.2% vs. 37.5%) when he compared the mortality rates of the malignant and the complication groups. Jungraithmayret al, [9] in their special series with a distinct complication group, reported that the complication group had significantly higher mortality rates than both the malignant and benign groups (33% vs. 10% and 0%, respectively).…”
Section: Study No Overall Mortality (%) Malignant (%) Benign (%) Overmentioning
confidence: 74%
“…[2][3][4][5][6][9][10][11][12][13][14][15][16][17] The overall 30-day mortality and late mortality rates of the current series were 14.8% and 22%, respectively, and the non-complication group had a much higher rate of mortality than the other group, although this was not statistically significant.…”
Section: Discussionmentioning
confidence: 96%